Knight Jeff E. (CIK 1881007) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-10). Recent activity: Buy CRNX (49,474 shares), Buy CRNX (9,624 shares), Buy CRNX (19,336 shares), Sell CRNX (85,163 shares), Sell CRNX (5,950 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-10 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Dev. & Operating Officer | Buy | 49,474 | $1.2M |
| 2026-04-10 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Dev. & Operating Officer | Buy | 9,624 | $192,672 |
| 2026-04-10 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Dev. & Operating Officer | Buy | 19,336 | $379,759 |
| 2026-04-10 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Dev. & Operating Officer | Sell | 85,163 | $3.4M |
| 2026-03-18 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | Sell | 5,950 | $220,804 |
| 2026-03-18 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | Sell | 3,961 | $149,607 |
| 2026-02-25 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | Buy | 34,000 | $0 |
| 2025-03-21 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | Sell | 6,801 | $232,390 |
| 2025-03-21 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | Sell | 361 | $12,574 |
| 2025-02-24 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Operating Officer | Buy | 43,000 | $0 |
Source: SEC Form 4 filings · as of 2026-04-10